Citation Impact
Citing Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
2012
Escitalopram
2005
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
2021
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
2010
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
2018 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Environmental Exposures and Adverse Pregnancy Outcomes: A Review of the Science
2008
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Vemurafenib in melanoma
2013
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
2017
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
2016 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Equipoise and the Dilemma of Randomized Clinical Trials
2011
Histamine receptors and cancer pharmacology
2010
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Health and Economic Implications of HPV Vaccination in the United States
2008
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Recent developments in pertussis
2006
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
2009
The reporting quality of meta-analyses improves: a random sampling study
2008
The neural basis of psychedelic action
2022 Standout
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
2010 Standout
Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?
2009
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Recurrent miscarriage
2006 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Epidemiologic Evidence of Relationships Between Reproductive and Child Health Outcomes and Environmental Chemical Contaminants
2008
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Literature review as a research methodology: An overview and guidelines
2019 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Caregiver Burden
2014 Standout
A Systematic Review of Systematic Reviews and Meta-Analyses of Animal Experiments with Guidelines for Reporting
2006
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Systematic review of compression following treatment for varicose veins
2015 StandoutNobel
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
2006
Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
2015 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Synthesizing qualitative research: a review of published reports
2007
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
Annual Research Review: A meta‐analysis of the worldwide prevalence of mental disorders in children and adolescents
2015 Standout
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of M. Hemels being referenced
Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
2004
Paternal organic solvent exposure and adverse pregnancy outcomes: A meta-analysis
2004
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder
2004
Advanced Cutaneous Malignant Melanoma: A Systematic Review of Economic and Quality-of-Life Studies
2007
Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada
2004
Clinical and Economic Factors in the Treatment of Behavioural and Psychological Symptoms of Dementia
2001
Treatments for metastatic melanoma: Synthesis of evidence from randomized trials
2007
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
2005
A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK
2005
Composite endpoints in trials of type‐2 diabetes
2013
Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis
2005
Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials
2003
Cost-Effectiveness of Escitalopram versus Citalopram in the Treatment of Severe Depression
2004